Lincoln Educational Services enters the final stretch before its August 3 earnings report with short sellers quietly but steadily rebuilding positions — even as the stock sits near multi-year highs and the analyst community remains firmly bullish.
The short interest story is the clearest tension here. Bears have added meaningfully over the past month, with SI climbing 31% to reach nearly 8.9% of the free float — a level that, while not extreme, demands attention given the speed of the move. The weekly build of 8.4% is particularly sharp. That accumulation has arrived despite a 16% price gain over the past month, meaning shorts are leaning into strength rather than chasing a falling stock. The ORTEX short score has drifted from 50.7 at the start of July to 53.4 today, a quiet but consistent drift that reflects this incremental repositioning.
What makes the positioning story more nuanced is that the lending market tells almost the opposite story. Borrow availability is exceptionally loose — at roughly 1,422% of outstanding short interest, there are far more shares available to lend than are currently borrowed. That figure has actually tightened from above 1,960% two weeks ago, which tracks with the SI build, but it remains nowhere near levels associated with squeeze risk. Cost to borrow has fallen 21% on the week to just 0.45%, about as cheap as it gets. The options market adds little urgency: the put/call ratio of 0.32 is essentially flat with its 20-day average of 0.32, and the z-score is negligible. Options traders are neither hedging aggressively nor loading up on calls. Positioning looks more like a patient short thesis than a high-conviction tactical bet.
The Street, by contrast, is clearly in the bull camp — though the most recent analyst actions are now over six weeks old and should be read in that context. Following the strong Q1 print in May, Rosenblatt, Barrington Research, and B. Riley Securities all raised targets, with Rosenblatt lifting to $60 and the other two moving to $56. The mean target of $57.40 sits about 7% above the current price of $53.51, which is modest upside for a stock that has already run 16% in a month. The factor scores reinforce the bull case selectively: EPS surprise ranks in the 94th percentile of the universe, and 90-day EPS momentum ranks 90th — the company has consistently beaten estimates. But the 12-month forward earnings growth score sits at just the 24th percentile, suggesting the Street sees the current beat streak as more reflective of execution than structural acceleration. At a trailing P/E of 52x and EV/EBITDA near 19.7x, the valuation is not cheap for an education services operator facing Title IV dependency risk.
The insider picture adds another layer of caution. Juniper Investment Company — a 10% owner and board member — sold aggressively through early June, offloading shares across multiple transactions totalling well over $7 million in that period alone. Other directors also trimmed. The net 90-day insider figure looks positive in aggregate, but that reflects older data; the recent directional signal from insiders has been clearly one of distribution into strength. Juniper's reduction from 5.46% of shares to current levels aligns neatly with the stock's run into the high $40s and low $50s. Among peers, closest correlate UTI fell nearly 9% on the week while PRDO managed a 3.3% gain — the education sector is not moving as a block, which isolates LINC's short build as a stock-specific rather than sector-wide phenomenon.
The last earnings print on May 11 produced a 12% single-day gain and held most of that move over five days — a result that clearly emboldened the analyst upgrades that followed. The August 3 report will therefore be judged against a much higher bar, and what matters most is whether enrollment trends and guidance commentary justify a 52x multiple on a business whose forward growth score ranks in the bottom quarter of the universe.
See the live data behind this article on ORTEX.
Open LINC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
